Feasibility and implementation of remote geriatric assessment–guided supportive care (GAIN-S) in public oncology settings.

C Cristiane Decat Bergerot (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) P Paulo Gustavo Bergerot (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) C Can-Lan Sun (City of Hope National Medical Center, Duarte, CA) M Marianne Razavi (City of Hope Comprehensive Cancer Center, Duarte, CA) R Rafaela Peixoto (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) G Gustavo de Oliveira Bretas (Oncoclínicas&Co/MedSir, Sao Paulo, Brazil) W William Hiromi Fuzita (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) M Mauro Daniel Spina Donadio (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) D Diocesio Alves Pinto Andrade (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) A Anne Caroline Furtado (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) J Jonas Ribeiro Gomes Silva (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) L Luciana Gomes Ladeira Carlos (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) J Jose Adolfo Cerveira (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) L Ludmila Rufatto Cora (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) R Renata Ferrari (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) P Pamela Carvalho Muniz (Oncoclinicas, São Paulo, Brazil) M Mariana Laloni (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) C Carlos Gil Ferreira (Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil) V Vani Katheria (City of Hope National Medical Center, Duarte, CA) W William Dale (City of Hope National Medical Center, Duarte, CA)

Abstract

1582 Background: The ASCO Global Guideline recommends routine geriatric assessment (GA) for adults aged ≥65 years with cancer to identify vulnerabilities beyond standard oncology evaluation and guide tailored management. However, real-world implementation of GA-guided interventions in low-resource settings remains limited. Building on prior feasibility work in private (PRI) oncology settings, we evaluated the feasibility and implementation of a remote, multidisciplinary GA-guided intervention in public (PUB) oncology settings in Brazil. Methods: We conducted a prospective feasibility and implementation study in PUB settings, with contextual reference to prior PRI experience. Patients aged ≥65 years initiating chemotherapy underwent baseline GA assessing functional status, depressive symptoms (GDS), cognitive screening (Mini-Cog), chemotherapy toxicity risk (CARG), nutritional status, and quality of life (FACT-G), with repeat assessment at 12 weeks. Identified impairments prompted referral to telehealth interventions (geriatrics, nutrition, psychology/psychiatry, exercise). Feasibility outcomes included recruitment, GA completion, referral recommendations, and follow-up retention. Implementation barriers in PUB settings were prospectively documented. Results: A total of 109 patients were included (PRI n=61; PUB n=48). The PUB cohort was younger (mean age 72 vs 76), included a higher proportion of Black participants (58% vs 44%), had lower education (no/limited 19% and elementary school 50% vs college degree 47%), and more advanced disease (92% stage III-IV vs 54% stage IV). Baseline geriatric vulnerability was similar (median CARG 6 vs 7, GDS 2); weight loss was more frequent in PUB (54% vs 36%). Quality of life was lower in PUB (FACT-G -5 points). GA identified actionable vulnerabilities, with 21% referred to ≥1 specialist (vs 33% in PRI) and 44% to ≥2 specialists (vs 28% in PRI). Key challenges included delayed recruitment, limited digital literacy (63%), restricted videoconferencing (73%), delays in nutritional supplements (38%), and exercise adaptation (50%), prompting ongoing, context-specific adaptations. Conclusions: Remote GA delivery and identification of actionable vulnerabilities were feasible in PUB settings in Brazil. Similar geriatric vulnerability profiles and characterization of implementation barriers support the scalability of GA-guided care in low-resource settings. Clinical trial information: NCT07084454 .

Article Details

Volume / Issue Vol. 44, Issue 16_suppl
Published June 01, 2026
Pages 1582-1582
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (20)

C

Cristiane Decat Bergerot

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

P

Paulo Gustavo Bergerot

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

C

Can-Lan Sun

City of Hope National Medical Center, Duarte, CA

M

Marianne Razavi

City of Hope Comprehensive Cancer Center, Duarte, CA

R

Rafaela Peixoto

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

G

Gustavo de Oliveira Bretas

Oncoclínicas&Co/MedSir, Sao Paulo, Brazil

W

William Hiromi Fuzita

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

M

Mauro Daniel Spina Donadio

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

D

Diocesio Alves Pinto Andrade

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

A

Anne Caroline Furtado

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

J

Jonas Ribeiro Gomes Silva

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

L

Luciana Gomes Ladeira Carlos

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

J

Jose Adolfo Cerveira

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

L

Ludmila Rufatto Cora

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

R

Renata Ferrari

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

P

Pamela Carvalho Muniz

Oncoclinicas, São Paulo, Brazil

M

Mariana Laloni

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

C

Carlos Gil Ferreira

Oncoclinicas&Co - Medica Scientia Innovation Research (MEDSIR), Sao Paulo, Brazil

V

Vani Katheria

City of Hope National Medical Center, Duarte, CA

W

William Dale

City of Hope National Medical Center, Duarte, CA